HE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocation

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Lokich, Elizabeth ^a   Singh, Rakesh K ^a   Han, Alex ^a   Romano, Nicole ^a   Yano, Naohiro ^a   Kim, Kyukwang ^a   Moore, Richard G ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; ESTRADIOL; FULVESTRANT; KARYOPHERIN; PROTEIN; TAMOXIFEN; WFDC2 PROTEIN, HUMAN;

ANALOGS AND DERIVATIVES; APOPTOSIS; CELL NUCLEUS; CELL PROLIFERATION; CONFOCAL MICROSCOPY; DRUG EFFECTS; DRUG RESISTANCE; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOPRECIPITATION; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; PROTEIN TRANSPORT; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; BLOTTING, WESTERN; CELL NUCLEUS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; KARYOPHERINS; MICROSCOPY, CONFOCAL; OVARIAN NEOPLASMS; PROTEIN TRANSPORT; PROTEINS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 84903639210     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05500     Document Type: Article

References (31)

1. Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2009). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. http://seer.cancer.gov/statfacts/html/ovary.html Date of access: 06/02/2014.
2. Cunat, S., Hoffmann, P. & Pujol, P. Estrogens and epithelial ovarian cancer. Gynecol Oncol 94, 25-32, doi:10.1016/j.ygyno.2004.03.026 (2004 (Pubitemid 38950494)
3. Sieh, W. et al. Hormone-receptor expression and ovarian cancer survival: An Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol 14, 853-862, doi:10.1016/S1470-2045(13)70253-5 (2013
4. Lau, K. M., Mok, S. C. & Ho, S. M. Expression of human estrogen receptor-alpha and-beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells. P Natl Acad Sci USA 96, 5722-5727 (1999 (Pubitemid 29234685)
5. Makar, A. P. Hormone therapy in epithelial ovarian cancer. Endocrin-Relat cancer 7, 85-93 (2000 (Pubitemid 30609987)
6. Shirey, D. R. et al. Tamoxifen therapy of epithelial ovarian cancer. Obstet Gynecol 66, 575-578 (1985 (Pubitemid 16236449)
7. Karagol, H. et al. The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer. Med Oncol 24, 39-43 (2007
8. Argenta, P. A. et al. A phase II study of fulvestrant in the treatment of multiplyrecurrent epithelial ovarian cancer. Gynecol Oncol 113, 205-209, doi:10.1016/j.ygyno.2009.01.012 (2009
9. Yokoyama, Y. &Mizunuma, H. Recurrent epithelial ovarian cancer and hormone therapy. World J Clin Cases 1, 187-190, doi:10.12998/wjcc.v1.i6.187 (2013
10. Hatch, K. D., Beecham, J. B., Blessing, J. A. & Creasman,W. T. Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. AGynecologic Oncology Group study of second-line therapy in 105 patients. Cancer 68, 269-271 (1991
11. Zhou, R., Treeck, O., Horn, F. & Ortmann, O. Effects of prolonged tamoxifen treatment on receptor expression and apoptosis of ovarian cancer cells. Gynecol Oncol 96, 678-683, doi:10.1016/j.ygyno.2004.11.023 (2005 (Pubitemid 40267684)
12. Pryor, M. J. et al. Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection. Traffic 8, 795-807, doi:10.1111/j.1600-0854.2007.00579.x (2007 (Pubitemid 46971628)
13. Moseley, G. W., Filmer, R. P., DeJesus, M. A. & Jans, D. A. Nucleocytoplasmic distribution of rabies virus P-protein is regulated by phosphorylation adjacent to C-terminal nuclear import and export signals. Biochemistry-US 46, 12053-12061, doi:10.1021/bi700521m (2007 (Pubitemid 350027404)
14. Hogarth, C. A., Calanni, S., Jans, D. A. & Loveland, K. L. Importin alpha mRNAs have distinct expression profiles during spermatogenesis. Dev Dynam 235, 253-262, doi:10.1002/dvdy.20569 (2006 (Pubitemid 46939722)
15. Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D. & Jans, D. A. Ivermectin is a specific inhibitor of importin alpha/beta-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem J 443, 851-856, doi:10.1042/BJ20120150 (2012
16. Vergote, I. & Abram, P. Fulvestrant, a new treatment option for advanced breast cancer: Tolerability versus existing agents. Ann Oncol 17, 200-204, doi:10.1093/annonc/mdj047 (2006 (Pubitemid 43160106)
17. Howell, A. et al. Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: A multinational, double-blind, randomized trial. J Clin Oncol 22, 1605-1613, doi:10.1200/JCO.2004.02.112 (2004 (Pubitemid 41079798)
18. Slotman, B. J.& Rao, B. R. Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemotherapy and endocrine therapy. Anticancer Res 8, 417-434 (1988
19. Wakeling, A. E., Dukes, M. & Bowler, J. A potent specific pure antiestrogen with clinical potential. Cancer Res 51, 3867-3873 (1991
20. Morris, C. & Wakeling, A. Fulvestrant ('Faslodex')-a new treatment option for patients progressing on prior endocrine therapy. Endocrin-Relat Cancer 9, 267-276 (2002 (Pubitemid 36240766)
21. Berry, N. B. et al. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter. Gynecol Oncol 92, 896-904, doi:10.1016/j.ygyno.2003.12.024 (2004 (Pubitemid 38251394)
22. Yoshida, T. et al. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: Methylation of the gene and alteration of trans-acting factors. Carcinogenesis 21, 2193-2201 (2000 (Pubitemid 32049225)
23. Counts, J. L. & Goodman, J. I. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83, 13-15 (1995
24. Robertson,K.D.DNAmethylation and human disease. Nat Rev Genet 6, 597-610, doi:10.1038/nrg1655 (2005 (Pubitemid 41044297)
25. Bird, A. DNA methylation patterns and epigenetic memory. Gene Dev 16, 6-21, doi:10.1101/gad.947102 (2002 (Pubitemid 34049633)
26. Gu, F. et al. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. BMC Syst Biol 4, 170, doi:10.1186/1752-0509-4-170 (2010
27. Ercoli, A. et al. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line. Int J Cancer 76, 47-54 (1998 (Pubitemid 28164568)
28. Moore, R. G. et al. HE4 (WFDC2) gene overexpression promotes ovarian tumor growth. Sci Rep 4, 3574, doi:10.1038/srep03574 (2014
29. Miyauchi, Y. et al. Importin 4 is responsible for ligand-independent nuclear translocation of vitamin D receptor. J Biol Chem 280, 40901-40908, doi:10.1074/jbc.M509347200 (2005 (Pubitemid 41780583)
30. Chachami, G. et al. Transport of hypoxia-inducible factor HIF-1alpha into the nucleus involves importins 4 and Biochem Bioph Res Co 390, 235-240, doi:10.1016/j.bbrc.2009.09.093 (2009
31. Lange, T. S. et al. Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model. Drug Des Devel Ther 3, 17-26 (2009).